(VIANEWS) - Peoples Bancorp (PEBO), Focus Financial Partners (FOCS), CONMED Corporation (CNMD) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Peoples Bancorp (PEBO)
38.2% sales growth and 8.03% return on equity
Peoples Bancorp Inc. is the holding company of Peoples Bank, which provides retail and commercial banking products and services.
Peoples Bancorp's sales growth this year is anticipated to be 31.3% and 8.4% for next year.
Year-on-year quarterly revenue growth grew by 41.8%, now sitting on 264.64M for the twelve trailing months.
Volume
Today's last reported volume for Peoples Bancorp is 71034 which is 24.95% below its average volume of 94657.
Peoples Bancorp's sales growth is a negative 0% for the ongoing quarter and 38.2% for the next. The company's growth estimates for the present quarter and the next is 43.1% and 375%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 8.03%.
Volatility
Peoples Bancorp's last day, last week, and last month's current intraday variation average was 0.91%, 1.20%, and 1.43%, respectively.
Peoples Bancorp's highest amplitude of average volatility was 2.79% (day), 2.22% (last week), and 2.96% (last month), respectively.
Peoples Bancorp's Stock Yearly Top and Bottom Value
Peoples Bancorp's stock is valued at $27.60 at 01:22 EST, way below its 52-week high of $34.63 and higher than its 52-week low of $26.56.
Peoples Bancorp's Moving Average
Peoples Bancorp's value is below its 50-day moving average of $29.73 and way under its 200-day moving average of $31.42.2. Focus Financial Partners (FOCS)
21.9% sales growth and 5.93% return on equity
Focus Financial Partners Inc. offers wealth management services for primarily high- and ultra-high net worth families and individuals as well as business entities.
Focus Financial Partners's sales growth this year is anticipated to be 22% and 17.9% for next year.
Year-on-year quarterly revenue growth grew by 36.1%, now sitting on 1.94B for the twelve trailing months.
Volume
Today's last reported volume for Focus Financial Partners is 442990 which is 5.35% above its average volume of 420487.
Focus Financial Partners's sales growth for the next quarter is 21.9%. The company's growth estimates for the ongoing quarter and the next is 12.2% and 13.3%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 5.93%.
Volatility
Focus Financial Partners's last day, last week, and last month's current intraday variation average was 0.27%, 1.23%, and 2.44%, respectively.
Focus Financial Partners's highest amplitude of average volatility was 2.44% (day), 3.69% (last week), and 4.82% (last month), respectively.
Focus Financial Partners's Stock Yearly Top and Bottom Value
Focus Financial Partners's stock is valued at $37.70 at 01:22 EST, way under its 52-week high of $69.13 and way above its 52-week low of $33.20.
Focus Financial Partners's Moving Average
Focus Financial Partners's value is below its 50-day moving average of $40.99 and way below its 200-day moving average of $52.15.3. CONMED Corporation (CNMD)
14.7% sales growth and 8.93% return on equity
CONMED Corporation is a global medical technology company that develops and manufactures minimally-invasive surgical equipment and other devices.
CONMED Corporation's sales growth this year is expected to be 10.7% and 9.5% for next year.
Year-on-year quarterly revenue growth grew by 4.1%, now sitting on 1.02B for the twelve trailing months.
Volume
Today's last reported volume for CONMED Corporation is 209197 which is 25.15% below its average volume of 279511.
CONMED Corporation's sales growth is a negative 0% for the present quarter and 14.7% for the next. The company's growth estimates for the ongoing quarter and the next is 5.6% and 15%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 8.93%.
Volatility
CONMED Corporation's last day, last week, and last month's current intraday variation average was 0.66%, 1.70%, and 3.07%, respectively.
CONMED Corporation's highest amplitude of average volatility was 2.79% (day), 3.25% (last week), and 4.34% (last month), respectively.
CONMED Corporation's Stock Yearly Top and Bottom Value
CONMED Corporation's stock is valued at $112.45 at 01:22 EST, way below its 52-week high of $159.11 and above its 52-week low of $107.08.
CONMED Corporation's Moving Average
CONMED Corporation's value is way below its 50-day moving average of $136.41 and way under its 200-day moving average of $137.04.4. InMode Ltd. (INMD)
10.7% sales growth and 48.58% return on equity
InMode Ltd.
InMode Ltd. 's sales growth this year is expected to be 18.2% and 14.7% for next year.
Year-on-year quarterly revenue growth grew by 31.1%, now sitting on 377.96M for the twelve trailing months.
Volume
Today's last reported volume for InMode Ltd. is 2605700 which is 19.42% above its average volume of 2181900.
InMode Ltd. 's sales growth for the next quarter is 10.7%. The company's growth estimates for the present quarter and the next is a negative 0% and negative -7.3%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 48.58%.
Volatility
InMode Ltd. 's last day, last week, and last month's current intraday variation average was 2.46%, 4.16%, and 5.04%, respectively.
InMode Ltd. 's highest amplitude of average volatility was 4.70% (day), 5.89% (last week), and 8.13% (last month), respectively.
InMode Ltd. 's Stock Yearly Top and Bottom Value
InMode Ltd. 's stock is valued at $26.64 at 01:22 EST, way below its 52-week high of $99.27 and way above its 52-week low of $20.60.
InMode Ltd. 's Moving Average
InMode Ltd. 's value is way below its 50-day moving average of $29.88 and way under its 200-day moving average of $56.55.5. Coca-Cola (KO)
10.5% sales growth and 42.06% return on equity
Coca-Cola Company is a global beverage manufacturer, marketer, and seller of non-alcoholic beverages.
Coca-Cola's sales growth this year is expected to be 8.5% and 5.3% for next year.
Year-on-year quarterly revenue growth grew by 16.3%, now sitting on 40.13B for the twelve trailing months.
Volume
Today's last reported volume for Coca-Cola is 9822450 which is 47.64% below its average volume of 18760700.
Coca-Cola's sales growth for the next quarter is 10.5%. The company's growth estimates for the current quarter and the next is a negative 1.5% and 1.5%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 42.06%.
Volatility
Coca-Cola's last day, last week, and last month's current intraday variation average was 1.21%, 1.08%, and 1.71%, respectively.
Coca-Cola's highest amplitude of average volatility was 1.29% (day), 1.94% (last week), and 2.45% (last month), respectively.
Coca-Cola's Stock Yearly Top and Bottom Value
Coca-Cola's stock is valued at $62.85 at 01:22 EST, below its 52-week high of $67.20 and way above its 52-week low of $52.28.